IP Library › Assignment 034167/0649
Patent Assignment
Reel/Frame 034167/0649

Assignment of Assignor's Interest

Recorded: 2014-11-13 Pages: 6
Assignor
ALNYLAM PHARMACEUTICALS, INC.
Executed: 2012-12-05
Assignee
TEKMIRA PHARMACEUTICALS CORPORATION
100-8900 GLENLYON PARKWAY, V5J 5J8, BURNABY BC, CANADA
Covered Property (1)
Targeting Lipids
Patent: 9,814,777 →
Application: 14/060,353 →
Publication: US 2014/0179761
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 13, 2014
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; NARAYANANNAIR, JAYAPRAKASH K.; JAYARAMAN, MUTHUSAMY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 034167/0605 →
Change of Name Aug 2, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 043175/0604 →
Merger and Change of Name Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →
Corrective Assignment to Correct the Errored Recording in 14/060,553. Remove from 14/060,553 and Record in 14/060,353 Shown at Page 2, Line 49 of 07/27/18 Cover Sheet Previously Recorded at Reel: 046640 Frame: 0764. Assignor(S) Hereby Confirms the Assignment. Jan 18, 2022
From: PROTIVA BIOTHERAPEUTICS INC.
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 058823/0636 →